Czech Republic: Registration Data Protection: Transition To The New System

Last Updated: 4 May 2005
Article by Karel Cermak Jr PhD

The registration data protection enables competitors in the field of medical preparations to ensure for a certain limited period of time exclusive rights to data gathered for testing the safety and effectiveness of a medical preparation, namely with respect to results of pharmacological and toxicological tests and clinical tests. This data generally must be filed with the administrative Office competent to register medical preparations for the purpose of approving the medical preparation for its launching on the market.

This data or its part may be and generally are protected through intellectually property rights, including patents, industrial designs, copy right, as well as protection of trade secret, respectively know how. This is complemented by the special protection provided pursuant to the respective regulations of pharmaceutical law. The respective regulations of the pharmaceutical law stipulate whether and under what conditions another applicant for registration of a medical preparation, other than the one, who has filed this data with the registration Office, may use this data in the registration proceedings relating to its own medical preparation.

In the Czech Republic, results of pharmacological and toxicological test and results of clinical trials of another owner of a decision on registration may be referred to provided that the medical preparation is essentially similar to the preparation that is already registered in the Czech Republic and that the owner of the decision on the registration of the original medical preparation has granted consent with the use of this data. If no such consent has been granted this data can be referred to only if the medical preparation is essentially similar to a medical preparation, which is registered in the Czech Republic, possibly in another state of the EU for at least the period of six years.

The interpretation of the EU directive setting out the protection for the registration data protection is a relatively common subject of decisions of the European Court of Justice. The European Court of Justice dealt apart from others with the question of how to interpret the term of essentially similar medical preparation and it defined it as a preparation that has identical qualitative and quantitative composition of the active substance, an identical pharmaceutical form and that is bio-equivalent, provided that it does not follow from the scientific knowledge that it differed from the original medical preparation as to its safety and effectiveness.

The European Court of Justice in the decision Generix (UK) Ltd. No. C-368/96 expressed a principle that if a medical preparation was essentially similar to an already registered medical preparation it was possible if other legal requirements were met to use the registration procedure with the reference to the data of the original preparation with respect to all therapeutic indications already authorized for the given preparation. The same applies to the dosage forms, doses and ways of dosage. In the decision Novartis Pharmaceutical UK Ltd. No. C-106/01 the ECS said that if so called hybrid administration abridged proceedings had been used for the registration of a medical preparation B, it was possible without a consent from the owner of the registration of this product and even though the six respectively ten year period of registration data protection had not lapsed yet, to refer to the registration data of this preparation when reviewing the application for registration of a medical preparation C, which referred to the medical preparation A, which had been approved for the period of more than six respectively ten years if the registration data of the medical preparation B lied in clinical tests that were to prove the safety of the product B even though this product had a higher degree of bioavailability than the product A if it was given in the same dosage. In the newest decision Approved Prescription Services Ltd. No. C-36/03 the European Court of Justice came to the conclusion that it was possible to refer to the preparation B, which was basically similar to the newly applied medical preparation if the product B was a new pharmaceutical form of the product A even though product A, not the product B had been approved in the EU for at least the period of six respectively 10 years.

A new system of registration data protection that will introduce the formula 8 + 2 + 1 will become effective next year. An application for registration of a generic medical preparation using the abridged procedure shall not be admissible before the expiration of the period of eight years from the registration of the original medical preparation in the EU or in another member state. However, the launching of a generic medical preparation on the market will be possible after the expiration of the period of ten years from the first registration of the original medical preparation. This ten-year period will be extended for a one more year provided that the owner of the registration receives during the first eights years from the ten-year period of protection an authorization for one or more new therapeutic indications that bring an important clinical benefit compared to the present ways of treatment. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions